The Hepatorenal Syndrome Treatment Market size is expected to grow at an annual average of 4% during 2022-2028. Hepatic nephrotic syndrome (HRS) is a unique form of renal failure due to reduced renal blood flow, usually in histologically normal kidneys. As a serious complication of advanced liver disease, it characteristically infects patients with cirrhosis and […]
